Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FFAR3 | O14843 | 2/20 | 0.87 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.87 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.87 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.87 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.87 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.55 |
| ▸ | GPR84 | Q9NQS5 | 7/20 | 0.52 |
| ▸ | PPARG | P37231 | 7/20 | 0.52 |
| ▸ | PPARD | Q03181 | 7/20 | 0.52 |
| ▸ | PPARA | Q07869 | 7/20 | 0.52 |
| ▸ | HDAC11 | Q96DB2 | 5/20 | 0.52 |
| ▸ | TSHR | P16473 | 4/20 | 0.52 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.52 |
| ▸ | TLR2 | O60603 | 2/20 | 0.52 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.52 |
| ▸ | FABP4 | P15090 | 2/20 | 0.52 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.52 |
| ▸ | SLC22A8 | Q8TCC7 | 1/20 | 0.52 |
| ▸ | MEN1 | O00255 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Butyric Acid SCHEMBL11626724 | 1.00 | FFAR3 (0.87) | FFAR3HDAC3HDAC1HDAC2HDAC8 | |
| Butyric Acid SCHEMBL11626727 | 1.00 | FFAR3 (0.87) | FFAR3HDAC3HDAC1HDAC2HDAC8 | |
| Butyric Acid SCHEMBL31286426 | 1.00 | FFAR3 (0.87) | FFAR3HDAC3HDAC1HDAC2HDAC8 | |
| Butyric Acid SCHEMBL11484161 | 0.97 | FFAR3 (0.81) | FFAR3HDAC3HDAC1HDAC2HDAC8 | |
| Butyric Acid SCHEMBL28519333 | 0.97 | FFAR3 (0.81) | FFAR3HDAC3HDAC1HDAC2HDAC8 | |
| Butyric Acid SCHEMBL9824028 | 0.94 | FFAR3 (0.77) | FFAR3HDAC3HDAC1HDAC2HDAC8 | |
| Butyric Acid SCHEMBL11042481 | 0.94 | FFAR3 (0.77) | FFAR3HDAC3HDAC1HDAC2HDAC8 | |
| Butyric Acid SCHEMBL11818808 | 0.94 | FFAR3 (0.77) | FFAR3HDAC3HDAC1HDAC2HDAC8 | |
| Butyric Acid SCHEMBL28299248 | 0.94 | FFAR3 (0.77) | FFAR3HDAC3HDAC1HDAC2HDAC8 | |
| Butyric Acid SCHEMBL27525465 | 0.94 | FFAR3 (0.77) | FFAR3HDAC3HDAC1HDAC2HDAC8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 246 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114349590-B | Method for synthesizing aromatic compound | 上海巽田科技股份有限公司 | 2024-01-30 | — | — | CN | claimed |
| CN-110392579-A | Mouse myopia induction model and endoplasmic reticulum stress inhibitor for myopia prevention/inhibition | 坪田实验室股份有限公司 | 2019-10-29 | — | — | CN | claimed |
| CN-110339181-A | A kind of pH response type nano preparation and its preparation method and application based on click-reaction | 中国药科大学 | 2019-10-18 | — | — | CN | claimed |
| CN-109010827-A | Chlorambucil-poly-dopamine prodrug nanoparticle antitumor application thereof | 上海交通大学 | 2018-12-18 | — | — | CN | claimed |
| CN-105289435-B | A kind of preparation method of magnetism self-repairing microcapsule | 中国船舶重工集团公司第七二五研究所 | 2018-10-23 | — | — | CN | claimed |
| CN-104812369-B | Core-shell particle, method for producing same, and composition containing core-shell particle | 心悦生医股份有限公司 | 2017-11-24 | — | — | CN | claimed |
| CN-104910045-B | Triad fullerene derivate and preparation method and application | 苏州大学 | 2017-08-01 | — | — | CN | claimed |
| CN-106554395-A | A kind of long acting erythropoietin simulating peptide and its preparation method and application | 天津药物研究院有限公司 | 2017-04-05 | — | — | CN | claimed |
| CN-105289435-A | Preparation method of magnetic self-repairing microcapsules | NO 725 RES INST CHINA CSIC | 2016-02-03 | — | — | CN | claimed |
| CN-104910045-A | Triad fullerene derivative and preparation method and application thereof | UNIV SOOCHOW | 2015-09-16 | — | — | CN | claimed |
| CN-102702838-B | Micro-crack self-repairing microcapsule and preparation method thereof | NO 725 RES INST CHINA CSIC | 2013-11-20 | — | — | CN | claimed |
| CN-102702838-A | Micro-crack self-repairing microcapsule and preparation method thereof | NO 725 RES INST CHINA CSIC | 2012-10-03 | — | — | CN | claimed |
| CN-102604469-A | Latent self-repair microcapsule and preparation method thereof | NO 725 RES INST CHINA CSIC | 2012-07-25 | — | — | CN | claimed |
| CN-101633625-A | Method for preparing R-beta-aminobenzene butyric acid derivative | JIANGSU HENGRUI MEDICINE CO | 2010-01-27 | — | — | CN | claimed |
| EP-1964836-A2 | A process for the preparation of perindopril erbumine in alpha crystalline form | IPCA Laboratories Limited (IN) | 2008-09-03 | — | — | EP | claimed |
| US-20080183011-A1 | Process for preparation of perindopril erbumine in alpha crystalline form | IPCA LABORATORIES LIMITED | 2008-07-31 | — | — | US | claimed |
| US-20050107350-A1 | Method for the treatment or prevention of bone disorders with a cyclooxygenase-2 inhibitor alone and in combination with a bone disorder treatment agent and compositions therewith | PHARMACIA CORPORATION (US) | 2005-05-19 | — | — | US | claimed |
| CN-116217585-B | Podophyllotoxin/epipodophyllotoxin derivative, preparation method and application thereof | 安徽工业大学 | 2025-05-27 | — | — | CN | disclosed |
| US-3933806-A | Cephalosporin michael adducts | ELI LILLY AND COMPANY (US) | 1976-01-20 | — | — | US | disclosed |
| US-3932479-A | BRONCHODILATOR, HYPOTENSIVE, ANTIULCER | AMERICAN CYANAMID COMPANY (US) | 1976-01-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050107350-A1 | Method for the treatment or prevention of bone disorders with a cyclooxygenase-2 inhibitor alone and in combination with a bone disorder treatment agent and compositions therewith | PTGS2, PTGES2, PTGS1 | FFAR3 2833/4885HDAC3 2646/4885HDAC1 2989/4885 |
| US-20080183011-A1 | Process for preparation of perindopril erbumine in alpha crystalline form | ACE, REN, ADH1C | FFAR3 1282/4885HDAC3 816/4885HDAC1 734/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.